Selected research
Industry Growth & Trends
Global AI Drug Safety Prediction Software Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global AI Drug Safety Prediction Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for AI Drug Safety Prediction Software is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for AI Drug Safety Prediction Software is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI Drug Safety Prediction Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the AI Drug Safety Prediction Software market include Certara, Lhasa Limited, Instem, ACD/Labs, Chemical Computing Group, Optibrium, MultiCASE, Insilico Medicine and MindRank, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global AI Drug Safety Prediction Software market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The AI Drug Safety Prediction Software market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global AI Drug Safety Prediction Software market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to AI Drug Safety Prediction Software.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global AI Drug Safety Prediction Software market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
AI Drug Safety Prediction Software Market by Company
Certara
Lhasa Limited
Instem
ACD/Labs
Chemical Computing Group
Optibrium
MultiCASE
Insilico Medicine
MindRank
Molecular Discovery
Molecular Networks
OASIS LMC
Simulations Plus
Dassault Systèmes
Schrödinger
AI Drug Safety Prediction Software Segment by Type
Integrated ADMET Prediction
Toxicity Endpoint Prediction
Drug-Drug Interaction and PK Safety Prediction
Metabolism and Metabolite Prediction
Off-Target and Safety Pharmacology Prediction
AI Drug Safety Prediction Software Segment by Application
Hit and Lead Screening
Lead Optimization
Candidate Selection
Preclinical Safety Assessment
Regulatory Safety Assessment
Other Drug Safety Research
AI Drug Safety Prediction Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Safety Prediction Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Drug Safety Prediction Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Safety Prediction Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of AI Drug Safety Prediction Software companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Integrated ADMET Prediction
- Toxicity Endpoint Prediction
- Drug-Drug Interaction and PK Safety Prediction
- Metabolism and Metabolite Prediction
- Off-Target and Safety Pharmacology Prediction
Applications
- Hit and Lead Screening
- Lead Optimization
- Candidate Selection
- Preclinical Safety Assessment
- Regulatory Safety Assessment
- Other Drug Safety Research
Companies covered
- Certara
- Lhasa Limited
- Instem
- ACD/Labs
- Chemical Computing Group
- Optibrium
- MultiCASE
- Insilico Medicine
- MindRank
- Molecular Discovery
- Molecular Networks
- OASIS LMC
- Simulations Plus
- Dassault Systèmes
- Schrödinger
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global AI Drug Safety Prediction Software Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global AI Drug Safety Prediction Software Market Size by Region (2021-2032)
- 1.4.1 Global AI Drug Safety Prediction Software Market Size by Region (2021-2026)
- 1.4.2 Global AI Drug Safety Prediction Software Market Size by Region (2027-2032)
- 1.5 Key Regions AI Drug Safety Prediction Software Market Size (2021-2032)
- 1.5.1 North America AI Drug Safety Prediction Software Market Size Growth Rate (2021-2032)
- 1.5.2 Europe AI Drug Safety Prediction Software Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific AI Drug Safety Prediction Software Market Size Growth Rate (2021-2032)
- 1.5.4 South America AI Drug Safety Prediction Software Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa AI Drug Safety Prediction Software Market Size Growth Rate (2021-2032)
2 AI Drug Safety Prediction Software Market by Type
- 2.1 Type Introduction
- 2.1.1 Integrated ADMET Prediction
- 2.1.2 Toxicity Endpoint Prediction
- 2.1.3 Drug-Drug Interaction and PK Safety Prediction
- 2.1.4 Metabolism and Metabolite Prediction
- 2.1.5 Off-Target and Safety Pharmacology Prediction
- 2.2 Global AI Drug Safety Prediction Software Market Size by Type
- 2.2.1 Global AI Drug Safety Prediction Software Market Size Overview by Type (2021-2032)
- 2.2.2 Global AI Drug Safety Prediction Software Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global AI Drug Safety Prediction Software Market Size Forecasted by Type (2027-2032)
- 2.3 Global AI Drug Safety Prediction Software Market Size by Regions
- 2.3.1 North America AI Drug Safety Prediction Software Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe AI Drug Safety Prediction Software Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific AI Drug Safety Prediction Software Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America AI Drug Safety Prediction Software Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa AI Drug Safety Prediction Software Market Size Breakdown by Type (2021-2026)
3 AI Drug Safety Prediction Software Market by Application
- 3.1 Type Introduction
- 3.1.1 Hit and Lead Screening
- 3.1.2 Lead Optimization
- 3.1.3 Candidate Selection
- 3.1.4 Preclinical Safety Assessment
- 3.1.5 Regulatory Safety Assessment
- 3.1.6 Other Drug Safety Research
- 3.2 Global AI Drug Safety Prediction Software Market Size by Application
- 3.2.1 Global AI Drug Safety Prediction Software Market Size Overview by Application (2021-2032)
- 3.2.2 Global AI Drug Safety Prediction Software Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global AI Drug Safety Prediction Software Market Size Forecasted by Application (2027-2032)
- 3.3 Global AI Drug Safety Prediction Software Market Size by Regions
- 3.3.1 North America AI Drug Safety Prediction Software Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe AI Drug Safety Prediction Software Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific AI Drug Safety Prediction Software Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America AI Drug Safety Prediction Software Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa AI Drug Safety Prediction Software Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 AI Drug Safety Prediction Software Industry Trends
- 4.2 AI Drug Safety Prediction Software Industry Drivers
- 4.3 AI Drug Safety Prediction Software Industry Opportunities and Challenges
- 4.4 AI Drug Safety Prediction Software Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by AI Drug Safety Prediction Software Revenue (2021-2026)
- 5.2 Global AI Drug Safety Prediction Software Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global AI Drug Safety Prediction Software Key Company Headquarters & Area Served
- 5.4 Global AI Drug Safety Prediction Software Company, Product Type & Application
- 5.5 Global AI Drug Safety Prediction Software Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global AI Drug Safety Prediction Software Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 AI Drug Safety Prediction Software Players Market Share by Revenue in 2025
- 5.6.3 2025 AI Drug Safety Prediction Software Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Certara
- 6.1.1 Certara Company Information
- 6.1.2 Certara Business Overview
- 6.1.3 Certara AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Certara AI Drug Safety Prediction Software Product Portfolio
- 6.1.5 Certara Recent Developments
- 6.2 Lhasa Limited
- 6.2.1 Lhasa Limited Company Information
- 6.2.2 Lhasa Limited Business Overview
- 6.2.3 Lhasa Limited AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Lhasa Limited AI Drug Safety Prediction Software Product Portfolio
- 6.2.5 Lhasa Limited Recent Developments
- 6.3 Instem
- 6.3.1 Instem Company Information
- 6.3.2 Instem Business Overview
- 6.3.3 Instem AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Instem AI Drug Safety Prediction Software Product Portfolio
- 6.3.5 Instem Recent Developments
- 6.4 ACD/Labs
- 6.4.1 ACD/Labs Company Information
- 6.4.2 ACD/Labs Business Overview
- 6.4.3 ACD/Labs AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 ACD/Labs AI Drug Safety Prediction Software Product Portfolio
- 6.4.5 ACD/Labs Recent Developments
- 6.5 Chemical Computing Group
- 6.5.1 Chemical Computing Group Company Information
- 6.5.2 Chemical Computing Group Business Overview
- 6.5.3 Chemical Computing Group AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Chemical Computing Group AI Drug Safety Prediction Software Product Portfolio
- 6.5.5 Chemical Computing Group Recent Developments
- 6.6 Optibrium
- 6.6.1 Optibrium Company Information
- 6.6.2 Optibrium Business Overview
- 6.6.3 Optibrium AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Optibrium AI Drug Safety Prediction Software Product Portfolio
- 6.6.5 Optibrium Recent Developments
- 6.7 MultiCASE
- 6.7.1 MultiCASE Company Information
- 6.7.2 MultiCASE Business Overview
- 6.7.3 MultiCASE AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 MultiCASE AI Drug Safety Prediction Software Product Portfolio
- 6.7.5 MultiCASE Recent Developments
- 6.8 Insilico Medicine
- 6.8.1 Insilico Medicine Company Information
- 6.8.2 Insilico Medicine Business Overview
- 6.8.3 Insilico Medicine AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Insilico Medicine AI Drug Safety Prediction Software Product Portfolio
- 6.8.5 Insilico Medicine Recent Developments
- 6.9 MindRank
- 6.9.1 MindRank Company Information
- 6.9.2 MindRank Business Overview
- 6.9.3 MindRank AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 MindRank AI Drug Safety Prediction Software Product Portfolio
- 6.9.5 MindRank Recent Developments
- 6.10 Molecular Discovery
- 6.10.1 Molecular Discovery Company Information
- 6.10.2 Molecular Discovery Business Overview
- 6.10.3 Molecular Discovery AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Molecular Discovery AI Drug Safety Prediction Software Product Portfolio
- 6.10.5 Molecular Discovery Recent Developments
- 6.11 Molecular Networks
- 6.11.1 Molecular Networks Company Information
- 6.11.2 Molecular Networks Business Overview
- 6.11.3 Molecular Networks AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Molecular Networks AI Drug Safety Prediction Software Product Portfolio
- 6.11.5 Molecular Networks Recent Developments
- 6.12 OASIS LMC
- 6.12.1 OASIS LMC Company Information
- 6.12.2 OASIS LMC Business Overview
- 6.12.3 OASIS LMC AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 OASIS LMC AI Drug Safety Prediction Software Product Portfolio
- 6.12.5 OASIS LMC Recent Developments
- 6.13 Simulations Plus
- 6.13.1 Simulations Plus Company Information
- 6.13.2 Simulations Plus Business Overview
- 6.13.3 Simulations Plus AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Simulations Plus AI Drug Safety Prediction Software Product Portfolio
- 6.13.5 Simulations Plus Recent Developments
- 6.14 Dassault Systèmes
- 6.14.1 Dassault Systèmes Company Information
- 6.14.2 Dassault Systèmes Business Overview
- 6.14.3 Dassault Systèmes AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Dassault Systèmes AI Drug Safety Prediction Software Product Portfolio
- 6.14.5 Dassault Systèmes Recent Developments
- 6.15 Schrödinger
- 6.15.1 Schrödinger Company Information
- 6.15.2 Schrödinger Business Overview
- 6.15.3 Schrödinger AI Drug Safety Prediction Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Schrödinger AI Drug Safety Prediction Software Product Portfolio
- 6.15.5 Schrödinger Recent Developments
7 North America
- 7.1 North America AI Drug Safety Prediction Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America AI Drug Safety Prediction Software Market Size by Country (2021-2026)
- 7.3 North America AI Drug Safety Prediction Software Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe AI Drug Safety Prediction Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe AI Drug Safety Prediction Software Market Size by Country (2021-2026)
- 8.3 Europe AI Drug Safety Prediction Software Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific AI Drug Safety Prediction Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific AI Drug Safety Prediction Software Market Size by Country (2021-2026)
- 9.3 Asia-Pacific AI Drug Safety Prediction Software Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America AI Drug Safety Prediction Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America AI Drug Safety Prediction Software Market Size by Country (2021-2026)
- 10.3 South America AI Drug Safety Prediction Software Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa AI Drug Safety Prediction Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa AI Drug Safety Prediction Software Market Size by Country (2021-2026)
- 11.3 Middle East & Africa AI Drug Safety Prediction Software Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst